CW
NVO

CIC Wealth’s Novo Nordisk NVO Stock Holding History

CIC Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.07M Sell
17,352
-559
-3% -$74.5K 0.53% 47
2024
Q2 		$2.56M Sell
17,911
-143
-0.8% -$18.9K 0.7% 33
2024
Q1 		$2.32M Sell
18,054
-864
-5% -$103K 0.67% 36
2023
Q4 		$1.96M Sell
18,918
-736
-4% -$72.8K 0.62% 40
2023
Q3 		$1.79M Sell
19,654
-482
-2% -$42.5K 0.64% 41
2023
Q2 		$1.63M Sell
20,136
-422
-2% -$34.5K 0.56% 41
2023
Q1 		$1.64M Sell
20,558
-694
-3% -$49.2K 0.62% 40
2022
Q4 		$1.44M Buy
+21,252
New +$1.25M 0.59% 46

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CIC Wealth's NVO Position: Q3 2024 in Review

CIC Wealth reduced its Novo Nordisk (NVO) stake by 3.1% in Q3 2024, selling an estimated $74.5K and leaving 17,352 shares worth $2.07M. The position accounts for 0.53% of the portfolio, ranked #47.

CIC Wealth first reported a position in NVO in Q4 2022 and has held it in 8 quarters since. The position peaked at $2.56M in Q2 2024. 1,786 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • CIC Wealth held 17,352 shares of Novo Nordisk worth $2.07M as of Q3 2024.
  • CIC Wealth sold 559 Novo Nordisk shares in Q3 2024, an estimated $74.5K.
  • Novo Nordisk made up 0.53% of CIC Wealth's portfolio in Q3 2024, its #47 holding.
  • CIC Wealth first reported a position in Novo Nordisk in Q4 2022 and has held it in 8 quarters since.
  • CIC Wealth's Novo Nordisk position peaked at $2.56M in Q2 2024.
  • 1,786 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on CIC Wealth's 13F filing for Q3 2024, filed 8 Nov 2024.